MaxLinear (MXL) PT Lowered to $90 at Roth Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/20/2026
- S&P 500, Nasdaq edge higher as chips recover; megacap earnings in focus
- Oil steadies as hopes of renewed US-Iran negotiations offset Houthi threat
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
- Why Moonshot AI's Kimi K3 is actually bullish for memory stocks
- AMC Entertainment soars on record quarterly results
- Cantor Fitzgerald Starts Trulieve Cannabis (TRLV) at Overweight, 'Purpose-Built for a New Cannabis Regulatory Framework'
- S&P 500, Nasdaq edge higher as chips recover; megacap earnings in focus
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
- Oil steadies as hopes of renewed US-Iran negotiations offset Houthi threat
- IREN raises 2026 revenue target to $4bn after $2.8bn in contracts
MaxLinear (MXL) PT Raised to $80 at Needham & Company
February 3, 2022 7:45 AM ESTNeedham & Company analyst N. Quinn Bolton raised the price target on MaxLinear (NASDAQ: MXL) to $80.00 (from $67.00) while maintaining a Buy rating.
The analyst commented, "Maxlinear reported 4Q21 revenue and NG GM toward the high-end of guidance, while delivering guidance for 1Q22 that was well... More
